/PRZWT/May 6, 2024, Jiangsu - As one of the first batch of innovative enterprises in the country named by the Ministry of Science and Technology, Yangzijiang Pharmaceutical Group has never lacked innovative genes, and in the process of promoting the development of new productivity across the country, Yangzijiang Pharmaceutical Group has once again taken the lead, accelerating innovation, exploration and practice, and continuously improving production efficiency and quality control.
Walking into the production workshop of Yangzijiang Pharmaceutical Group, all you can see is a busy scene of intelligent production. Under the command of the intelligent control center, robots are deftly waving their robotic arms and methodically selecting, packing, and palletizing medicinal materials in the production workshop. Workers are rarely seen in the workshop, reflecting the vitality of new productivity everywhere.
Taking the road of digital transformation is an important breakthrough point for traditional manufacturing enterprises to develop new quality productivity. In the "14th Five-Year" Digital Economy Development Plan, it is clear that the digital economy will promote profound changes in production methods and lifestyles. The digital economy is a key force in reshaping the global competition landscape.
In this regard, Yangzijiang Pharmaceutical Group has a clear understanding. The person in charge of the group said that for Yangzijiang Pharmaceutical Group, an important part of developing new quality productivity is to continue to promote "smart transformation and digital transformation", activate the huge potential of manufacturing "ballast stone", and comprehensively build and improve its own digital manufacturing system. It is necessary to accelerate the completion of the shortcomings and weaknesses of all aspects of the group through the application of advanced production technologies such as digitalization, intelligence and networking, and achieve lean production, and promote the double improvement of product quality and production efficiency.
Yangzijiang Pharmaceutical Group said so, and it is doing so. In 2023, Jiangsu Longfengtang Traditional Chinese Medicine Co., Ltd., a subsidiary of the group, passed the acceptance of the National Standards Committee's "National High-tech Industry Standardization Pilot for Intelligent Manufacturing of Traditional Chinese Medicine Process", becoming the first recognized traditional Chinese medicine intelligent manufacturing enterprise in Jiangsu Province; its Guangzhou Hairui Pharmaceutical Co., Ltd. has realized data lake visualization and precise regulation management in product inventory, warehousing environment management, etc., and was successfully selected as the National Intelligent Manufacturing Excellent Scene.
On the quality management side, Yangzijiang Pharmaceutical Group is also constantly innovating practices and improving quality and efficiency. By setting up a "quality management cockpit" on the production line, the group's quality management has been standardized, automated and refined, the management and control efficiency has reached a new level, and operating costs have been further reduced. At the same time, Yangzijiang Pharmaceutical Group is also actively benchmarking international advanced standards, accelerating international certifications such as drug production quality management standards (GMP), and upgrading intelligent production workshops that comply with international quality management standards. At present, the group has a total of 5 workshops, 7 preparations, and 1 extract that have passed the European Union GMP certification, and 2 workshops, 1 API, and 1 preparation have passed the Australian TGA GMP certification, gaining more competitive confidence in the international arena.
